Key statistics
On Wednesday, Pharming Group NV (PHGN:DUS) closed at 0.874, -18.39% below its 52-week high of 1.07, set on Jun 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.874 |
---|---|
High | 0.874 |
Low | 0.874 |
Bid | 0.8735 |
Offer | 0.888 |
Previous close | 0.8595 |
Average volume | 1.62k |
---|---|
Shares outstanding | 685.15m |
Free float | 666.00m |
P/E (TTM) | -- |
Market cap | 599.32m EUR |
EPS (TTM) | -0.0184 EUR |
Data delayed at least 15 minutes, as of Jul 09 2025 07:10 BST.
More ▼
Announcements
- Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
- Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
- Pharming Group to participate in June investor conferences
- Pharming Group reports first quarter 2025 financial results and provides business update
- Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
- Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
- Pharming Group to report first quarter 2025 financial results on May 8
- Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
- Pharming Group announces the filing of its 2024 Annual Report and Form 20-F
- Pharming Group to participate in April investor conferences
More ▼